A new drug (566C80) for the treatment of Pneumocystis carinii pneumonia.
Hughes
W T
WT
D000935:Antifungal Agents / Q000627:therapeutic use*; D053626:Atovaquone; D015658:HIV Infections / Q000150:complications; D006801:Humans; D009285:Naphthoquinones / Q000627:therapeutic use*; D009894:Opportunistic Infections / Q000150:complications / Q000188:drug therapy; D011020:Pneumonia, Pneumocystis / Q000150:complications / Q000188:drug therapy*
D000935:Antifungal Agents; D009285:Naphthoquinones; D053626:Atovaquone